RECRUITING

Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to enhance the care of older metastatic gastric cancer (mGC) patients by increasing awareness among oncology providers of the unique aspects of care required for older patients. The goal of the study is to educate providers on the utility of geriatric assessment in guiding therapy of older mGC patients. The investigators will also assess the feasibility and benefit of incorporating geriatric self-assessments into clinical practice. The study will include four phases.

Official Title

Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer

Quick Facts

Study Start:2020-09-22
Study Completion:2023-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04618809

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Ability to read and understand English, ability to sign consent, and complete a self-assessment evaluation.
  2. 2. Evidence of mGC (mGE junction cancer allowed). Patients can be enrolled at any stage of their treatment or disease course.
  3. 3. Ongoing active therapy for mGC. Patients can be treated with any type of therapy including chemotherapy, immunotherapy or Her-2 targeted therapy.
  4. 4. Life expectancy ≥3 months.
  1. 1. ≤69 years old.
  2. 2. Inability to read and understand English.
  3. 3. No evidence of mGC.
  4. 4. Not on active therapy.
  5. 5. Life expectancy \<3 months.

Contacts and Locations

Study Contact

Efrat Dotan, MD
CONTACT
215-214-4283
Efrat.Dotan@fccc.edu

Study Locations (Sites)

Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111
United States
Temple University Hospital
Philadelphia, Pennsylvania, 19140
United States

Collaborators and Investigators

Sponsor: Fox Chase Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-09-22
Study Completion Date2023-12-31

Study Record Updates

Study Start Date2020-09-22
Study Completion Date2023-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Metastatic Gastric Cancer